Segments (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014		Mar. 31, 2013	Dec. 31, 2013
Segment Reporting Information [Line Items]
Product revenues	$ 19,828		$ 15,527
Revenue from services	1,970		3,092
Revenue from transfer of intellectual property	476		12,757
Operating (loss) income	(30,277)		(6,773)
Depreciation and amortization	3,564		3,429
Total revenues	22,274		31,376
Assets	1,355,692	[1]		1,391,516	[1]
Goodwill	226,062	[1]		226,373	[1]
United States [Member]
Segment Reporting Information [Line Items]
Total revenues	2,446		15,849
Chile [Member]
Segment Reporting Information [Line Items]
Total revenues	7,285		7,741
Spain [Member]
Segment Reporting Information [Line Items]
Total revenues	6,150		4,324
Israel [Member]
Segment Reporting Information [Line Items]
Total revenues	4,546		2,572
Mexico [Member]
Segment Reporting Information [Line Items]
Total revenues	1,831		890
Uruguay [Member]
Segment Reporting Information [Line Items]
Total revenues	16		0
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Product revenues
Revenue from services	60		40
Revenue from transfer of intellectual property	0		0
Operating (loss) income	(6,137)		(5,025)
Depreciation and amortization	24		45
Assets	174,329			209,539
Goodwill	0			0
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Operating (loss) income	(489)		(597)
Pharmaceutical [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Product revenues	19,828		15,527
Revenue from services	0		0
Revenue from transfer of intellectual property	285		12,500
Operating (loss) income	(16,573)		8,483
Depreciation and amortization	1,849		1,695
Assets	1,067,848			1,065,033
Goodwill	175,097			175,408
Diagnostics [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Product revenues
Revenue from services	1,910		3,052
Revenue from transfer of intellectual property	191		257
Operating (loss) income	(7,078)		(9,634)
Depreciation and amortization	1,691		1,689
Assets	113,515			116,944
Goodwill	$ 50,965			$ 50,965

[1] As of March 31, 2014 and December 31, 2013, total assets include $6.8 million and $6.7 million, respectively, and total liabilities include $11.4 million and $10.4 million, respectively, related to SciVac Ltd (“SciVac”), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 5.